Inspire Advisors, LLC Neurocrine Biosciences Inc Transaction History

Inspire Advisors, LLC

  • $737 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023
SELL
$94.02 - $117.1 $463,518 - $577,303
-4,930 Reduced 52.02%
4,548 $511,000
Q2 2023

Jul 31, 2023
BUY
$89.53 - $104.87 $110,480 - $129,409
1,234 Added 14.97%
9,478 $893,000
Q1 2023

Apr 24, 2023
BUY
$94.11 - $123.02 $775,842 - $1.01 Million
8,244 New
8,244 $834,000

Others Institutions Holding NBIX

# of Institutions
625
Shares Held
94.2M
Call Options Held
632K
Put Options Held
621K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Inspire Advisors, LLC Portfolio

Follow Inspire Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email